Plain-English translation of NCT06855537 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether placing a stent (a small tube that props open a narrowed artery) in your coronary artery can prevent future heart attacks when combined with intensive heart medications. You will be randomly assigned to either receive the stent procedure plus aggressive medications, or to take aggressive medications alone. The trial wants to know if the stent procedure offers extra protection beyond what medications alone can provide.
Some heart artery blockages are dangerous but not yet severely narrowed. Doctors are trying to figure out whether fixing these early, risky blockages with a stent can prevent heart attacks, or whether aggressive medications alone are enough to keep you safe.
You likely qualify if…
You likely don't qualify if…
If you are randomly assigned to the stent group, you will undergo a catheterization procedure to place the stent, followed by intensive medications including cholesterol-lowering drugs and blood thinners for about 12 months. If you are assigned to the medication-only group, you will take intensive medications without the stent procedure. Both groups will have follow-up visits and imaging tests to monitor your heart health over time. The study involves approximately 2,190 participants total.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
China